Castle Biosciences (CSTL)
(Delayed Data from NSDQ)
$33.15 USD
-1.52 (-4.38%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $32.95 -0.20 (-0.60%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *AMC11/4/24 |
---|---|
Current Quarter | -0.06 |
EPS Last Quarter | 0.31 |
Last EPS Surprise | 293.75% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.59 |
Next Year | -2.15 |
EPS (TTM) | -0.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 78.55M | 61.27M | 299.80M | 279.54M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 78.55M | 61.27M | 299.80M | 279.54M |
Low Estimate | 78.55M | 61.27M | 299.80M | 279.54M |
Year ago Sales | 61.49M | 66.12M | 219.79M | 299.80M |
Year over Year Growth Est. | 27.75% | -7.33% | 36.41% | -6.76% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.06 | -0.82 | -0.59 | -2.15 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | -0.06 | -0.82 | -0.69 | -1.98 |
High Estimate | -0.06 | -0.82 | -0.48 | -1.98 |
Low Estimate | -0.06 | -0.82 | -0.69 | -2.32 |
Year ago EPS | -0.26 | -0.10 | -2.14 | -0.59 |
Year over Year Growth Est. | 76.92% | -720.00% | 72.43% | -265.25% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 1 |
Down Last 60 Days | 0 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.06 | -0.82 | -0.59 | -2.15 |
7 Days Ago | -0.06 | -0.82 | -0.59 | -2.15 |
30 Days Ago | -0.08 | -0.80 | -0.58 | -2.13 |
60 Days Ago | -0.08 | -0.80 | -1.28 | -2.15 |
90 Days Ago | -0.66 | -0.52 | -1.66 | -1.91 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.06 | -0.82 | -0.69 | -1.98 |
Zacks Consensus Estimate | -0.06 | -0.82 | -0.59 | -2.15 |
Earnings ESP | 0.00% | 0.00% | -17.95% | 7.91% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.31 | -0.09 | -0.10 | -0.26 | NA |
Estimate | -0.16 | -0.37 | -0.84 | -0.92 | NA |
Difference | 0.47 | 0.28 | 0.74 | 0.66 | 0.54 |
Surprise | 293.75% | 75.68% | 88.10% | 71.74% | 132.32% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more